Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Chihiro Morishima"'
Autor:
Lei Yu, Sarim Yousuf, Shahrukh Yousuf, Jeffrey Yeh, Scott W. Biggins, Chihiro Morishima, Irene Shyu, Galen O’Shea-Stone, Brian Eilers, Annie Waldum, Valérie Copié, Jason Burkhead
Publikováno v:
Hepatology Communications. 7:e0076-e0076
Autor:
Chihiro Morishima, Gyongyi Szabo, Jules L. Dienstag, Deepa Naishadham, Elizabeth C. Wright, Anna S.F. Lok, Adrian M. Di Bisceglie, Marc G. Ghany, Karen L. Lindsay, Gregory T. Everson, Mitchell L. Shiffman, Timothy R. Morgan
Publikováno v:
American Journal of Gastroenterology. 107:1388-1398
During the Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial, 3.5 years of maintenance peginterferon-alfa-2a therapy did not affect liver fibrosis progression or clinical outcomes among 1,050 previous interferon nonresponders with adv
Autor:
Marc G. Ghany, Herbert L. Bonkovsky, Karen L. Lindsay, Leonard B. Seeff, Elizabeth C. Wright, Hae-Young Kim, Jules L. Dienstag, Chihiro Morishima, Anna S.F. Lok, Gregory T. Everson, Gyongyi Szabo, William M. Lee, James E. Everhart, Richard K. Sterling, Anne M. Stoddard, Timothy R. Morgan, Adrian M. Di Bisceglie
Publikováno v:
Hepatology. 54:396-405
The incidence of liver disease progression among subjects with histologically advanced but compensated chronic hepatitis C is incomplete. The Hepatitis C Antiviral Long-term Treatment against Cirrhosis Trial was a randomized study of 3.5 years of mai
Autor:
Jules L. Dienstag, S. Russell Nash, Elizabeth C. Wright, Herbert L. Bonkovsky, A. Scott Mills, Sugantha Govindarajan, Chihiro Morishima, Elizabeth M. Brunt, Heather J. Litman, John C. Hoefs, Thomas E. Rogers, James E. Everhart, David E. Kleiner, Zachary D. Goodman, Joel K. Greenson, Marc G. Ghany
Publikováno v:
Hepatology. 51:585-594
Studies of the prognostic value of Ishak fibrosis stage are lacking. We used multi-year follow-up of the Hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial to determine whether individual Ishak fibrosis stages predicted clinic
Autor:
William M. Lee, Joel K. Greenson, Chihiro Morishima, Raymong T. Chung, Karen L. Lindsay, Herbert L. Bonkovsky, Anna S. Lok, Marc G. Ghany, Adrian M. Di Bisceglie, Gregory T. Everson, James E. Everhart, John C. Hoefs, Richard K. Sterling, Hae-Young Kim
Publikováno v:
Hepatology. 49:1828-1837
Hepatic steatosis is a common histologic feature in patients with chronic hepatitis C and has been reported to be associated with fibrosis in cross-sectional studies.1–3 However, very few studies have examined paired biopsies to determine the relat
Autor:
Teresa M. Curto, James E. Everhart, Chihiro Morishima, Gregory T. Everson, Timothy R. Morgan, Mitchell L. Shiffman, Minjun C. Apodaca, Anna S.F. Lok, Marc G. Ghany, Jules L. Dienstag, Karen L. Lindsay, David R. Gretch, Elizabeth C. Wright, William M. Lee
Publikováno v:
Hepatology. 48:1412-1419
The Siemens VERSANT® transcription-mediated amplification (TMA) assay is extremely sensitive for the detection of hepatitis C virus (HCV) RNA in serum. Eleven of 180 subjects in the Hepatitis C Antiviral Long-term Treatment against Cirrhosis (HALT-C
Autor:
Anthony E. T. Yeo, Christina S. Yoshihara, Brent L. Wood, David R. Gretch, Scott S. Emerson, Chia C. Wang, Denise M. Paschal, Chihiro Morishima, Margaret C. Shuhart
Publikováno v:
Hepatology. 43:573-580
Prior studies have suggested that natural killer (NK) cell function might be impaired in chronic hepatitis C virus (HCV) infection. Circulating NK cell frequency and cytolytic activity were examined freshly ex vivo in HCV-infected and uninfected subj
Autor:
Chihiro Morishima, Anna S.F. Lok, Mitchell L. Shiffman, Jules L. Dienstag, Herbert L. Bonkovsky, Leonard B. Seeff, William M. Lee, Marc G. Ghany, John C. Hoefs, Deepa Naishadham, Adrian M. Di Bisceglie, Jeffrey Kahn, Gregory T. Everson
Publikováno v:
Hepatology. 44:1675-1684
In patients with chronic hepatitis C, advanced fibrosis and cirrhosis are associated with lower rates of sustained virologic response (SVR) to interferon (IFN)-based therapy. In this study, we assessed virologic response to retreatment with peginterf
Autor:
Adrian M. Di Bisceglie, David R. Gretch, Timothy R. Morgan, Herbert L. Bonkovsky, Jules L. Dienstag, Karen L. Lindsay, Mitchell L. Shiffman, Anna S.F. Lok, Marc G. Ghany, William M. Lee, Elizabeth C. Wright, Chihiro Morishima, James E. Everhart, Gregory T. Everson
Publikováno v:
Hepatology. 44:360-367
For making treatment decisions related to chronic hepatitis C, the utility of HCV RNA tests with increased sensitivity has not been defined. Prior interferon nonresponders with advanced fibrosis (n = 1,145) were retreated with peginterferon alpha-2a
Publikováno v:
Hepatology. 48:345-346